Strain-specific behavior of Mycobacterium tuberculosis in A549 lung cancer cell line.

Elastic net penalized logistic regression Lineage Lung Cancer Mycobacterium tuberculosis

Journal

BMC bioinformatics
ISSN: 1471-2105
Titre abrégé: BMC Bioinformatics
Pays: England
ID NLM: 100965194

Informations de publication

Date de publication:
25 Mar 2021
Historique:
received: 12 12 2020
accepted: 23 03 2021
entrez: 26 3 2021
pubmed: 27 3 2021
medline: 13 4 2021
Statut: epublish

Résumé

A growing body of evidence has shown the association between tuberculosis (TB) infection and lung cancer. However, the possible effect of strain-specific behavior of Mycobacterium tuberculosis (M.tb) population, the etiological agent of TB infection in this association has been neglected. In this context, this study was conducted to investigate this association with consideration of the genetic background of strains in the M.tb population. We employed the elastic net penalized logistic regression model, as a statistical-learning algorithm for gene selection, to evaluate this association in 129 genes involved in TLRs and NF-κB signaling pathways in response to two different M.tb sub-lineage strains (L3-CAS1and L 4.5). Of the 129 genes, 21 were found to be associated with the two studied M.tb sub-lineages. In addition, MAPK8IP3 gene was identified as a novel gene, which has not been reported in previous lung cancer studies and may have the potential to be recognized as a novel biomarker in lung cancer investigation. This preliminary study provides new insights into the mechanistic association between TB infection and lung cancer. Further mechanistic investigations of this association with a large number of M.tb strains, encompassing the other main M.tb lineages and using the whole transcriptome of the host cell are inevitable.

Sections du résumé

BACKGROUND BACKGROUND
A growing body of evidence has shown the association between tuberculosis (TB) infection and lung cancer. However, the possible effect of strain-specific behavior of Mycobacterium tuberculosis (M.tb) population, the etiological agent of TB infection in this association has been neglected. In this context, this study was conducted to investigate this association with consideration of the genetic background of strains in the M.tb population.
RESULTS RESULTS
We employed the elastic net penalized logistic regression model, as a statistical-learning algorithm for gene selection, to evaluate this association in 129 genes involved in TLRs and NF-κB signaling pathways in response to two different M.tb sub-lineage strains (L3-CAS1and L 4.5). Of the 129 genes, 21 were found to be associated with the two studied M.tb sub-lineages. In addition, MAPK8IP3 gene was identified as a novel gene, which has not been reported in previous lung cancer studies and may have the potential to be recognized as a novel biomarker in lung cancer investigation.
CONCLUSIONS CONCLUSIONS
This preliminary study provides new insights into the mechanistic association between TB infection and lung cancer. Further mechanistic investigations of this association with a large number of M.tb strains, encompassing the other main M.tb lineages and using the whole transcriptome of the host cell are inevitable.

Identifiants

pubmed: 33765916
doi: 10.1186/s12859-021-04100-z
pii: 10.1186/s12859-021-04100-z
pmc: PMC7992940
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

154

Références

Cancer Res. 2012 Aug 15;72(16):3948-57
pubmed: 22673234
Cytokine. 2018 Apr;104:53-64
pubmed: 29032986
Cell Death Dis. 2013 Dec 05;4:e951
pubmed: 24309938
Cancer Lett. 2007 Oct 28;256(2):137-65
pubmed: 17629396
Tuberculosis (Edinb). 2016 Mar;97:73-85
pubmed: 26980499
Nat Protoc. 2008;3(6):1101-8
pubmed: 18546601
J Biol Chem. 2013 May 17;288(20):14531-14543
pubmed: 23576431
ACS Med Chem Lett. 2015 Oct 18;6(12):1179-83
pubmed: 26713101
Cell Physiol Biochem. 2018;47(5):2097-2108
pubmed: 29975933
Mol Clin Oncol. 2017 Apr;6(4):494-502
pubmed: 28413655
Medicine (Baltimore). 2016 Jan;95(4):e2352
pubmed: 26825880
Drug Discov Today Dis Mech. 2010 Spring;7(1):e43-e59
pubmed: 21076640
Mol Phylogenet Evol. 2019 Mar;132:46-52
pubmed: 30513341
Genes Dev. 2006 Jan 15;20(2):225-35
pubmed: 16384933
J Korean Med Sci. 2013 Jun;28(6):896-900
pubmed: 23772155
Semin Cancer Biol. 2004 Jun;14(3):149-54
pubmed: 15246049
J Womens Health (Larchmt). 2009 Dec;18(12):1989-95
pubmed: 20044861
Biomed Pharmacother. 2010 Jan;64(1):58-62
pubmed: 19879105
PLoS One. 2012;7(8):e43170
pubmed: 22916219
Mol Med Rep. 2017 Jun;15(6):3963-3968
pubmed: 28487954
Cancer Lett. 2013 May 28;332(2):141-50
pubmed: 21071136
J Thorac Oncol. 2015 Jan;10(1 Suppl 1):S1-63
pubmed: 25535693
Biochem Biophys Res Commun. 2015 Feb 6;457(2):177-82
pubmed: 25554695
Eur Respir J. 2016 Sep;48(3):889-902
pubmed: 27174888
Trends Pharmacol Sci. 2017 Mar;38(3):226-256
pubmed: 28012700
Clin Cancer Res. 2004 Jun 15;10(12 Pt 2):4227s-4232s
pubmed: 15217963
J Thorac Oncol. 2011 Jan;6(1):32-7
pubmed: 21150470
Genomics. 2020 Mar;112(2):1223-1232
pubmed: 31306748
Mol Cancer. 2011 Dec 23;10:152
pubmed: 22195643
BMC Infect Dis. 2021 Jan 4;21(1):2
pubmed: 33397308
Lancet Infect Dis. 2007 May;7(5):328-37
pubmed: 17448936
Oncol Rep. 2017 Aug;38(2):685-692
pubmed: 28627635
Nat Rev Microbiol. 2018 Apr;16(4):202-213
pubmed: 29456241
Clin Cancer Res. 2016 May 15;22(10):2329-34
pubmed: 27016309
Sci Rep. 2018 Oct 25;8(1):15775
pubmed: 30361509
Am J Cancer Res. 2016 Sep 01;6(9):1935-1948
pubmed: 27725900
PLoS One. 2013 Jun 26;8(6):e67277
pubmed: 23840651
J Immunol. 2007 Sep 1;179(5):3332-41
pubmed: 17709550
J Immunol. 2008 Mar 1;180(5):2886-93
pubmed: 18292510
Small GTPases. 2016 Jul 2;7(3):123-38
pubmed: 27104658
Annu Rev Immunol. 2007;25:267-96
pubmed: 17134371
Mol Cell Biol. 2009 Sep;29(17):4831-40
pubmed: 19564410
Int J Clin Oncol. 2017 Dec;22(6):1026-1033
pubmed: 28748356
Neoplasia. 2004 Nov-Dec;6(6):744-50
pubmed: 15720800
Pneumonol Alergol Pol. 2015;83(4):298-302
pubmed: 26166791
Cancer. 2011 Feb 1;117(3):618-24
pubmed: 20886634
J Immunol. 2007 Nov 1;179(9):6228-36
pubmed: 17947698
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Am J Respir Cell Mol Biol. 2011 Feb;44(2):230-7
pubmed: 20395632
Nat Rev Cancer. 2003 Jun;3(6):401-10
pubmed: 12778130
Int J Cancer. 2002 Aug 20;100(6):706-13
pubmed: 12209611
J Cell Physiol. 2019 Apr;234(4):4739-4753
pubmed: 30192006
Hematol Oncol Clin North Am. 2004 Oct;18(5):1007-21, viii
pubmed: 15474332
Lung Cancer. 2015 Sep;89(3):311-9
pubmed: 26122346
Int J Clin Exp Pathol. 2014 Oct 15;7(11):8096-104
pubmed: 25550857

Auteurs

Shima Hadifar (S)

Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran.
Microbiology Research Center (MRC), Pasteur Institute of Iran, Tehran, Iran.

Shayan Mostafaei (S)

Department of Biostatistics, School of Health, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Epidemiology and Biostatistics Unit, Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran.

Ava Behrouzi (A)

Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran.
Microbiology Research Center (MRC), Pasteur Institute of Iran, Tehran, Iran.

Abolfazl Fateh (A)

Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran.
Microbiology Research Center (MRC), Pasteur Institute of Iran, Tehran, Iran.

Parisa Riahi (P)

Department of Biostatistics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.

Seyed Davar Siadat (SD)

Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran.
Microbiology Research Center (MRC), Pasteur Institute of Iran, Tehran, Iran.

Farzam Vaziri (F)

Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran. farzam_vaziri@yahoo.com.
Microbiology Research Center (MRC), Pasteur Institute of Iran, Tehran, Iran. farzam_vaziri@yahoo.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH